Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thalamic neurodegeneration in multiple sclerosis.

Alberto Cifelli1, Marzena Arridge, Peter Jezzard

  • 1Centre for Functional Magnetic Resonance Imaging of the Brain, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.

Annals of Neurology
|October 29, 2002
PubMed
Summary

Multiple sclerosis involves significant gray matter damage, specifically substantial thalamic neuronal loss (30-35%). This neurodegenerative pathology likely contributes significantly to multiple sclerosis symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An automated quantitative report for multiple sclerosis using only 3D T2-fluid-attenuated inversion recovery MRI.

Neuroradiology·2026
Same author

The 2024 McDonald criteria for the diagnosis of multiple sclerosis: implications for clinical practice.

Practical neurology·2026
Same author

A Case of Voltage-Gated Calcium Channel and TG6 Antibody-Positive Cerebellar Ataxia.

Case reports in neurological medicine·2026
Same author

Structure-function multilayer network integration and cognition in multiple sclerosis.

Network neuroscience (Cambridge, Mass.)·2026
Same author

Identification of genetic risk loci associated with aquaporin 4-positive neuromyelitis optica spectrum disorder: a genome-wide association study.

The Lancet. Neurology·2026
Same author

Myelin oligodendrocyte glycoprotein antibody-associated disease and relapse risk: Effects of smoking and vascular risk factors.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Area of Science:

  • Neuroscience
  • Neurology
  • Pathology

Background:

  • Multiple sclerosis (MS) traditionally viewed as a white matter disease.
  • Emerging evidence indicates significant gray matter involvement in MS.
  • Thalamic pathology in MS remains under-investigated.

Purpose of the Study:

  • To quantify thalamic neuronal loss in patients with multiple sclerosis.
  • To investigate the contribution of gray matter neurodegeneration to MS pathology.

Main Methods:

  • In vivo magnetic resonance imaging (MRI) and spectroscopy.
  • Postmortem histopathological analysis.
  • Estimation of neuronal loss in the thalamus.

Main Results:

Related Experiment Videos

  • Substantial neuronal loss observed in the thalamus of MS patients.
  • Quantified reduction in thalamic neurons ranging from 30% to 35%.
  • Evidence supports significant gray matter neurodegeneration in MS.

    • Conclusions:

    • Neurodegeneration in gray matter, particularly the thalamus, is a major feature of MS.
    • Thalamic neuronal loss significantly contributes to the development of MS symptoms.
    • Re-evaluation of MS as a disease with substantial neurodegenerative components is warranted.